Uncategorized

Lilly and Boehringer roll back billions in German investments over health budget cuts

Lilly and Boehringer roll back billions in German investments over health budget cuts

Published

on

With Germany moving to curb healthcare spending, Eli Lilly and Boehringer Ingelheim have rethought plans to invest in facilities, including a manufacturing plant for GLP-1 drugs.​ ​Read More

Leave a Reply

Your email address will not be published. Required fields are marked *

Trending

Exit mobile version